The Industry

January 2007
Pharmaceutical Representative;Jan2007, Vol. 37 Issue 1, p10
The article presents news briefs related to the pharmaceutical industry in the United States as of January 1, 2007. Abbott Laboratories has made an offer to purchase Kos Pharmaceuticals Inc. for 3.7 billion dollars. Merck & Co. Inc. has signed a definitive agreement to acquire Sirna Therapeutics Inc.


Related Articles

  • Pharmaceutical Company Round-up.  // PharmaWatch: Monthly Review;Dec2006, Vol. 5 Issue 12, p3 

    The article offers news briefs related to pharmaceutical companies in the U.S. Merck & Co. Inc. has reported a drop in profits on flat sales due to its lawsuits over the drug Vioxx. A district court has allowed the appeal of Johnson & Johnson for a preliminary injunction against Mylan...

  • Abbott's new pill is a tough sell. Colias, Mike // Crain's Chicago Business;12/4/2006, Vol. 29 Issue 49, p2 

    The article reports that Abbott Laboratories Inc. has placed a big bet on good cholesterol (HDL)-boosting drugs with its proposed $3.7-billion acquisition of Kos Pharmaceuticals Inc. as more and more physicians nowadays are prescribing exercise and a healthier diet for to increase HDL. Abbott...

  • A billion dollar punt.  // Nature Biotechnology;Dec2006, Vol. 24 Issue 12, p1453 

    Merck's acquisition of Sirna Therapeutics is a gamble, but gambling may not always be such a bad thing.

  • Merck & Co.: Sirna takeover heralds end of alliance.  // PharmaWatch: Monthly Review;Nov2007, Vol. 6 Issue 11, p36 

    The article reports on the end of Alnylam Pharmaceuticals Inc. and Merck & Co. Inc.'s research partnership in the U.S. According to the article, the reason for the separation is the latter's move to complete a $1.1 billion takeover by Sirna Therapeutics Inc. In addition, Alnylam has decided to...

  • Biotech Gets Good Marks for 2006, Faces Challenges.  // njbiz;4/23/2007, Vol. 20 Issue 17, p2 

    The article focuses on the financial performance of the biotechnology industry in the U.S. in 2006, according to a report released by Ernst & Young global accounting and consulting firm in April 2007. The report says that drug companies in New Jersey played an important role in the performance...

  • CORPORATE.  // MondayMorning;12/21/2009, Vol. 17 Issue 49, p2 

    The article offers news briefs related to the mergers and acquisition of corporates related to the healthcare industry. The largest health-products company of the world, Johnson & Johnson plans to buy Acclarent Inc. for 785 million dollars. Merck Sharp & Dohme Ltd., a subsidiary of Merck & Co....

  • PRIVATE VIEW∣ADS. Moss, Chet // Medical Marketing & Media;Oct2006, Vol. 41 Issue 10, p98 

    The article presents advertising campaigns of the pharmaceutical industry in the U.S. Abbott Laboratories Inc. has launched Hytrin for benign prostatic hyperplasia. Pfizer Inc. promoted Viagra through the advertising agency McCann Erickson. Merck & Co. Inc. has launched Zoloft for people with...

  • 3Q sales of locally produced drugs reach $20.1 billion. Martinez, Marialba // Caribbean Business;11/20/2003, Vol. 31 Issue 46, p16 

    Reports on the increased sales of drugs produced in Puerto Rico during the third quarter of 2003. Total value of sales; Top sales performances by Pfizer Inc., Merck & Co., Bristol-Myers Squibb, Abbott Laboratories, Amgen, Eli-Lilly & Co., Schering-Plough Corp. and Wyeth; Strong results of the...

  • News in brief.  // Nature Reviews Drug Discovery;Jul2010, Vol. 9 Issue 7, p505 

    The article offers news briefs related to pharmaceutical industry. Abbott Laboratories Inc. has acquired Piramal's Healthcare Solutions business to strengthen the company's position in the branded generics market. Merck and Co. Inc. has launched a collaborative oncology trial network to address...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics